e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
A morphological view of chest pathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinic and radiologic features and outcomes of amidrone induced alveolities under the influence of steroid treatment
Natalya Yakovleva (Saint-Petersburg, Russian Federation), N. Yakoleva, A. Speranskaya, G. Orlova, V. Amosov, V. Zolotnitskaya
Source:
International Congress 2015 – A morphological view of chest pathology
Session:
A morphological view of chest pathology
Session type:
Thematic Poster Session
Number:
760
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Natalya Yakovleva (Saint-Petersburg, Russian Federation), N. Yakoleva, A. Speranskaya, G. Orlova, V. Amosov, V. Zolotnitskaya. Clinic and radiologic features and outcomes of amidrone induced alveolities under the influence of steroid treatment. Eur Respir J 2015; 46: Suppl. 59, 760
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Factors predicting resolution in nitrofurantoin-induced lung disease
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Familial pulmonary fibrosis: Clinical-functional and radiological features
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Can current guidelines improve the diagnosis of a usual interstitial pneumonia among general radiologists?
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Clinical characteristics of anti-Jo-1-positive interstitial lung disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Effects of limb training in symptomatic patients with interstitial lung disease of different severity and etiology: A pilot study
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014
Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Interstitial lung disease caused by filamin A gene mutations: Clinical course of three paediatric cases
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
Progression pattern of CT findings in patients with RAS after lung transplantation
Source: International Congress 2014 – From lung imaging research to clinical use
Year: 2014
Statin-induced lung diseases
Source: International Congress 2016 – Sarcoidosis
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept